Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ADP vs EMR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EMR Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 3–7 Matrix Metrics)

EMR Overall Winner 6-Pillar Tally: ADP 3 – 3 EMR Matrix Metrics: ADP 7 – 3 EMR

As of Nov 16, 2026, Emerson Electric Co. (EMR) is the stronger overall head-to-head candidate over Automatic Data Processing (ADP) in the Tradestie Institutional Equity Comparison Engine, winning 3–7 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). ADP carries a Unified Composite Score of 41.6/100 (SELL) at $313.83 (25.4x Forward P/E, 26.7% operating margin), whereas EMR carries 51.2/100 (HOLD) at $161.06 (22.9x Forward P/E, 24.8% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ADP vs EMR
ADP NASDAQ
Automatic Data Processing
Services-Computer Processing & Data Preparation
$313.83
+1.26% 1D
Market Cap $121.6B
TTM Revenue $22.3B
Forward P/E 25.4x
Beta / 30D Vol -0.35β · 28% Vol
Unified Composite Score
41.6 / 100 SELL
Tech 25.0 Fund 43.0 Flow 55.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 70
RSI-14: 69.8 · SMA20: $300.73 · SMA50: $282.13
EMR NYSE Head-to-Head Winner
Emerson Electric Co.
Electronic & Other Electrical Equipment (No Computer Equip)
$161.06
-3.2% 1D
Market Cap $91.6B
TTM Revenue $19.0B
Forward P/E 22.9x
Beta / 30D Vol 1.45β · 34% Vol
Unified Composite Score
51.2 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 59.0 Mom 45.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.2 · SMA20: $165.18 · SMA50: $159.74

6-Pillar Scorecard Institutional Category Breakdown (ADP 3 – 3 EMR)

Columns: Metric · ADP · EMR
1. Valuation Multiples EMR
Forward P/E 25.4x 22.9x
Trailing P/E 27.3x 34.9x
PEG Ratio 2.82x 2.02x
EV / Revenue 5.5x 5.4x
2. Growth & Scale EMR
Revenue Growth (YoY) +6.1% +7.1%
Earnings Growth (YoY) +13.7% +23.8%
TTM Revenue (USD) $22.3B $19.0B
Market Cap $121.6B $91.6B
3. Profitability & Quality ADP
Gross Margin 48.8% 52.7%
Operating Margin 26.7% 24.8%
Net Profit Margin 20.3% 14.2%
Return on Equity (ROE) 78.9% 13.1%
4. Balance Sheet & Cash Flow ADP
Cash Generation (TTM) $4.76B $3.54B
Cash Flow Margin 21.4% 18.6%
Net Cash / Leverage $2.00B Net Debt (1.04x D/E) $11.1B Net Debt (0.62x D/E)
Dividend Yield 2.22% 1.33%
5. Options & Positioning ADP
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 47.9% (39th %ile) 46.6% (6th %ile)
Put/Call OI Skew 0.29x (Call-Skewed) 0.40x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat EMR
OpEx & R&D Intensity 22.1% of Rev ($4.92B) 27.9% of Rev ($5.30B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role Software - Application Operator Specialty Industrial Machinery Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ADP (7) vs EMR (3)
Institutional Metric ADP EMR Criterion Row Edge
Market Capitalization
Scale
$121.6B $91.6B Larger Scale ADP
Trailing P/E Ratio
Valuation
27.3x 34.9x Lower Multiple ADP
Forward P/E Ratio
Valuation
25.4x 22.9x Lower Multiple EMR
Revenue Growth (YoY)
Growth
+6.1% +7.1% Higher Growth EMR
Operating Margin (TTM)
Profitability
26.7% 24.8% Higher Margin ADP
Net Profit Margin
Profitability
20.3% 14.2% Higher Margin ADP
Return on Equity (ROE)
Capital Efficiency
78.9% 13.1% Higher ROE ADP
52-Week Range Position
Momentum
98% ($188–$316) 78% ($123–$172) Stronger Trend ADP
Beta / 30D Volatility
Risk Regime
-0.35β · 28% Vol 1.45β · 34% Vol Lower Realized Risk ADP
Unified Institutional Score
Composite Signal
41.6 / 100 (SELL) 51.2 / 100 (HOLD) Higher Composite EMR
Trailing 12M Revenue (USD)
Operating Scale
$22.3B $19.0B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
48.8% 52.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.82x PEG · 5.5x EV/Rev 2.02x PEG · 5.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$4.76B ($2.00B Net Debt (1.04x D/E)) $3.54B ($11.1B Net Debt (0.62x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ADP +8.88 pp
ADP: +8.63% · EMR: -0.25%
3M Horizon ADP +14.45 pp
ADP: +16.53% · EMR: +2.08%
6M Horizon ADP +18.96 pp
ADP: +40.77% · EMR: +21.81%
1Y Horizon EMR +2.12 pp
ADP: +23.26% · EMR: +25.38%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ADP Revenue EMR Revenue ADP Op. Margin EMR Op. Margin Margin Leader
FY2019 $14.1B $18.4B 16.2% 12.6% ADP
FY2020 $14.6B $16.8B 16.9% 11.7% ADP
FY2021 $15.0B $12.9B 17.3% 17.8% EMR
FY2022 $16.5B $13.8B 17.9% 23.4% EMR
FY2023 $18.0B $15.2B 18.9% 87.2% EMR
FY2024 $19.2B $17.5B 19.5% 11.3% ADP
FY2025 $20.6B $18.0B 19.8% 12.6% ADP
FY2026 $21.9B $19.0B 20.1% 14.2% ADP

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ADP CONSOLIDATION
55d in phase · OBV ACCUMULATION
Current IV 47.9%
IV Percentile 39th %ile
Put/Call OI Skew 0.29x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact ADP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EMR CONSOLIDATION
68d in phase · OBV DISTRIBUTION
Current IV 46.6%
IV Percentile 6th %ile
Put/Call OI Skew 0.40x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ADP Moat Profile High-Margin Pricing Power Moat
Software - Application Operator
Competes within the Software - Application value chain with $121.6B market capitalization and 26.7% operating margin.
OpEx & R&D Reinvestment 22.1% of Rev ($4.92B)
90D Engineering Disclosures 0 Published
EMR Moat Profile Scale & Operating Efficiency Moat
Specialty Industrial Machinery Operator
Competes within the Specialty Industrial Machinery value chain with $91.6B market capitalization and 24.8% operating margin.
OpEx & R&D Reinvestment 27.9% of Rev ($5.30B)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (15 partners):
Taiwan Semiconductor Manufacturing Company Amkor Technology ASE Technology Holding Cadence Design Systems

Investor FAQ ADP vs EMR Key Questions & Quantitative Answers

As of Nov 16, 2026, Emerson Electric Co. (EMR) is the stronger overall head-to-head candidate over Automatic Data Processing (ADP) in the Tradestie Institutional Equity Comparison Engine, winning 3–7 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, R&D & Supply-Chain Moat). ADP carries a Unified Composite Score of 41.6/100 (SELL) at $313.83 (25.4x Forward P/E, 26.7% operating margin), whereas EMR carries 51.2/100 (HOLD) at $161.06 (22.9x Forward P/E, 24.8% operating margin). Technically, ADP sits in a Markup phase (RSI 69.8, CONSOLIDATION options structure) and EMR sits in a Neutral phase (RSI 46.2, CONSOLIDATION options structure).

EMR leads the Growth & Scale pillar: ADP posts +6.1% YoY revenue growth and +13.7% YoY earnings growth on $22.3B TTM revenue (48.8% gross margin, 26.7% operating margin), compared with EMR at +7.1% YoY revenue growth and +23.8% YoY earnings growth on $19.0B TTM revenue (52.7% gross margin, 24.8% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), ADP cumulative revenue shifted +55.6% while EMR shifted +3.3%. In operating R&D and SG&A reinvestment, ADP deploys 22.1% of Rev ($4.92B) (0 90-day corporate R&D disclosures) versus 27.9% of Rev ($5.30B) (0 disclosures) for EMR.

EMR screens cheaper on headline valuation multiples. ADP trades at 25.4x Forward P/E, 27.3x Trailing P/E, 2.82x PEG, and 5.5x EV/Revenue (21.4% FCF margin), whereas EMR trades at 22.9x Forward P/E, 34.9x Trailing P/E, 2.02x PEG, and 5.4x EV/Revenue (18.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ADP (78.9% ROE) versus EMR (13.1% ROE) capital efficiency.

In options market volatility and institutional positioning, ADP carries 47.9% implied volatility (39th %ile, Balanced (25th–60th %ile)), a 0.29x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.35β · 28% Vol realized risk). By comparison, EMR carries 46.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.40x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.45β · 34% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.